logo

NCEL

NewcelXยทNASDAQ
--
--(--)
--
--(--)

NCEL Profile

Newcelx Ltd.

A clinical-stage biopharmaceutical company that developing innovative therapies for rare and complex central nervous system disorders

Pharmaceutical
--
01/29/2021
NASDAQ Stock Exchange
3
12-31
Common stock
The Circle 6, 8058 Zurich, Switzerland
--
NewcelX Ltd., was established in June 2015. The company is an innovative biopharmaceutical company dedicated to the discovery and development of life-enhancing drug therapies for rare central nervous system diseases.